POSACONAZOLE is a Oral Tablet, Delayed Release in the Human Prescription Drug category. It is labeled and distributed by Lannett Company Inc.. The primary component is Posaconazole.
| Product ID | 0527-2133_386712ec-571f-4dfa-ab3b-cc68fbf07185 |
| NDC | 0527-2133 |
| Product Type | Human Prescription Drug |
| Proprietary Name | POSACONAZOLE |
| Generic Name | Posaconazole |
| Dosage Form | Tablet, Delayed Release |
| Route of Administration | ORAL |
| Marketing Start Date | 2019-08-28 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA212411 |
| Labeler Name | Lannett Company Inc. |
| Substance Name | POSACONAZOLE |
| Active Ingredient Strength | 100 mg/1 |
| Pharm Classes | Azole Antifungal [EPC],Azoles [CS] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2021-12-31 |
| Marketing Start Date | 2021-01-31 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | ANDA |
| Application Number | ANDA212411 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2019-08-28 |
| Marketing Category | ANDA |
| Application Number | ANDA212411 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-08-28 |
| Ingredient | Strength |
|---|---|
| POSACONAZOLE | 100 mg/1 |
| SPL SET ID: | 94a9b028-a2bc-4f41-884d-2d6c536881fc |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| UPC Code |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0254-2045 | POSACONAZOLE | posaconazole |
| 0406-7711 | POSACONAZOLE | posaconazole |
| 0527-2133 | POSACONAZOLE | Posaconazole |
| 60687-523 | Posaconazole | Posaconazole |
| 70748-258 | POSACONAZOLE | POSACONAZOLE |
| 0085-1328 | NOXAFIL | posaconazole |
| 0085-2224 | NOXAFIL | posaconazole |
| 0085-4324 | NOXAFIL | posaconazole |
| 0085-4331 | NOXAFIL | posaconazole |